Well your mindsets seem to be to stick with the same ol same ol ...cos eventually ....eventually , the entire Cardiology community will see the light and start aggressively writing scripts ..especially in the EU
Meanwhile ...do the math here, Q1 24 over Q1 23 saw a 41% decrease in US revenues . Similar will happen in Q2 and Q3 and Q4 because the major health providers like Kaiser have switched to generic V or are forcing AMRN to beat generic pricing to retain their market share .
Great deal ..hey we have retained our US market share ...but were losing $ doing it ..but never mind
And while this is going on in the US ...script growth ( except in Spain ) is barely moving .
But lets stick with the same ol same ol ...with a $50m share buy back thrown in so mgt options that vest next April, can maybe cash in .
Cos thats the best idea we ( mgt ) can come up with .
Kiwi
News 
Market Data 
Discover 
